Email this article Evaluation of the relationship of disease activity with neutrophile to lymphocyte ratio and platelet to lymphocyte ratio in patients with peptic ulcer and gastritis
Abstract
Background: Dyspepsia is a confusing complaint in terms of patient approach and management. Since the most important clinical diagnoses that occur with dyspeptic complaints are gastroduodenitis, peptic ulcer disease and gastric-esophageal cancers, endoscopic evaluation method is often preferred in the diagnosis. It has been shown that NLR (neutrophil to lymphocyte ratio) can be an important marker in many chronic systemic diseases, especially malignancies. Since upper gastrointestinal endoscopy is an invasive and costly procedure, NLR and PLR (Platelet to lymphocyte ratio) may be useful as a new marker to help in the diagnosis of gastritis and peptic ulcer. In our study, we aimed to investigate how NLR and PLR changes seen in patients with gastritis and peptic ulcer diseases.
Methods: A total of 906 patients who applied to the internal medicine clinic of our hospital between January 2016 and September 2017 were included in the study. The demographic data, drugs, endoscopy and biopsy results and hemogram parameters of the patients were obtained from the outpatient clinic records. NLR and PLR values were calculated and statistically interpreted.
Results: According to the endoscopy results, a total of 906 patients with 311 (34.3%) gastritis, 288 (31.8%) peptic ulcer and 307 (33.9%) normal findings were included in to the study. Male to female ratios were 55% to 45% in gastritis patients, 55,6% to 44,4% in peptic ulcer patients and 53,4% to 46,6% in normal subjects. The median age of the patients was 50 years (18-82 years). The median NLR and PLR ratios were 1.82 (0.54-8.35) and 107.8 (46.27-446.43) in the gastritis group, 1.9 (0.61-9.86) in the peptic ulcer group and 110.95 (44.03-340.65) and 1.71 (0.56-12.89) and 106.02 (40.41-397.62) in the normal group. While a significant difference was obtained between the groups in terms of NLR ((p=0.048), no significant difference was found for PLR (p=0.422).
Conclusions: In our study, a statistical significant difference was found between patients with gastritis and peptic ulcer and normal subjects in terms of NLR, but this difference was not at a level that could be used in clinical practice.
Keywords
Full Text:
PDFReferences
Talley NJ, Goodsall T, Potter M. Functional dyspepsia. Aust Prescr. 2017;40(6):209-13.
Lee SW, Chang CS, Yeh HJ, Lien HC, Lee TY, Penga YC. The Diagnostic Value of Alarm Features for Identifying Types and Stages of Upper Gastrointestinal Malignancies. Gastroenterol. Res. 2017;10(2):120-5.
Grivennikov SI, Greten FR, Karin M. Immunity, inflammation, and cancer. Cell. 2010; 19;140(6):883-99.
Bancroft AJ, Abel EW, Mclaren M, Belch JJ. Mean platelet volume is a useful parameter: a reproducible routine method using a modified Coulter thrombocytometer. Platelets. 2000;11(7):379-87.
Hirashima M, Higuchi S, Sakamoto K, Nishiyama T, Okada H. The ratio of neutrophils to lymphocytes and the phenotypes of neutrophils in patients with early gastric cancer. J Cancer Res Clin Oncol. 1998;124(6):329-34.
Rashid F, Waraich N, Bhatti I, Saha S, Khan RN, Ahmed J et al. A pre-operative elevated neutrophil: lymphocyte ratio does not predict survival from oesophageal cancer resection. World J Surg Oncol. 2010;8:1.
Shimada H, Takiguchi N, Kainuma O, Soda H, Ikeda A, Cho A et al. High preoperative neutrophil-lymphocyte ratio predicts poor survival in patients with gastric cancer. Gastric Cancer. 2010;13(3):170-6.
Talley NJ, Ford AC. Functional Dyspepsia. N Engl J Med. 2015;373(19):1853-63.
Delaney BC, Wilson S, Roalfe A. Randomised controlled trial of Helicobacter pylori testing and endoscopy for dyspepsia in primary care. BMJ. 2001;322:898-901.
Templeton AJ, McNamara MG, Šeruga B, Vera-Badillo FE, Aneja P, Ocaña A, et al. Prognostic role of neutrophil-to-lymphocyte ratio in solid tumors: a systematic review and meta-analysis. J Natl Cancer Inst. 2014;106(6):124.
Zheng J, Cai J, Li H, Zeng K, He L, Fu H, et al. Neutrophil to Lymphocyte Ratio and Platelet to Lymphocyte Ratio as Prognostic Predictors for Hepatocellular Carcinoma Patients with Various Treatments: a Meta-Analysis and Systematic Review. Cell Physiol Biochem. 2017;44(3):967-81.
Dell'Aquila E, Cremolini C, Zeppola T, Lonardi S, Bergamo F, Masi G, et al. Prognostic and predictive role of neutrophil/lymphocytes ratio in metastatic colorectal cancer: a retrospective analysis of the TRIBE study by GONO. Ann Oncol. 2018.
Piciucchi M, Stigliano S, Archibugi L, Zerboni G, Signoretti M, Barucca V et al. The Neutrophil/Lymphocyte Ratio at Diagnosis Is Significantly Associated with Survival in Metastatic Pancreatic Cancer Patients. Int J Mol Sci. 2017;18(4):E730.
Varım C, Acar BA, Uyanık MS, Acar T, Alagoz N, Nalbant A, et al. Association between the neutrophil-to-lymphocyte ratio, a new marker of systemic inflammation, and restless legs syndrome. Singapore Medical J. 2016 57(9), 514.
Cengiz H, Varim C, Demirci T, Cetin S. Hemogram parameters in the patients with subacute thyroiditis. Pakistan J Medic Sci. 2020;36(2):240.
Şenel E, Acar B, Demir E. Mean Platelet Volume: A Reliable Marker of Inflammation in Recurrent Apthous Stomatitis and Behçet Disease? Indian Dermatol Online J. 2017;8(6):468-70.
Celikbilek M, Dogan S, Gursoy S, Zararsız G, Yurci A, Ozbakır O ve ark. Noninvasive assessment of liver damage in chronic hepatitis B. World J Hepatol. 2013;5(8):43945.
Yamanaka T, Matsumoto S, Teramukai S, Ishiwata R, Nagai Y, Fukushima M. The baseline ratio of neutrophils to lymphocytes is associated with patient prognosis in advanced gastric cancer. Oncol. 2007;73(3-4):215-20.
Mao M, Wei X, Sheng H, Chi P, Liu Y, Huang X et al. C-reactive protein/albumin and neutrophil/lymphocyte ratios and their combination predict overall survival in patients with gastric cancer. Oncol Lett. 2017;14(6):7417-24.
Wang SC, Chou JF, Strong VE, Brennan MF, Capanu M, Coit DG. Pretreatment Neutrophil to Lymphocyte Ratio Independently Predicts Disease-specific Survival in Resectable Gastroesophageal Junction and Gastric Adenocarcinoma. Ann Surg. 2016;263(2):292-7.
Xu ZS, Zhang FP, Zhang Y, Ou-Yang YP, Yu XW, Wang WL et al. Prognostic role of the pre-treatment platelet-lymphocyte ratio in pancreatic cancer: a meta-analysis. Oncotarget. 2017;8(58):99003-99012.
Zhao QT, Zhang XP, Zhang H, Duan GC. Prognostic role of platelet to lymphocyte ratio in esophageal cancer: A meta-analysis. Oncotarget. 2017;8(67):112085-112093.
Varım C, Varim P, Acar BA, Vatan MB, Uyanık MS, Kaya T, Akdemir R. Usefulness of the platelet-to-lymphocyte ratio in predicting the severity of carotid artery stenosis in patients undergoing carotid angiography. The Kaohsiung J Medic Sci. 2016; 32(2):86-90.
Jia-Wei Zhang, Lei Huang, A-Man Xu. Preoperative monocyte-lymphocyte and neutrophillymphocyte but not platelet-lymphocyte ratios are predictive of clinical outcomes in resected patients with non-metastatic Siewert type II/III adenocarcinoma of esophagogastric junction: a prospective cohort study (the AMONP corhort) Oncotarget, 2017;34:57516.
Gao Y, Wang WJ, Zhi Q, Shen M, Jiang M, Bian X et al. Neutrophil/lymphocyte ratio is a more sensitive systemic inflammatory response biomarker than platelet/lymphocyte ratio in the prognosis evaluation of unresectable pancreatic cancer. Oncotarget. 2017;8(51):88835-44.
Guclu M, Faruq Agan A. Association of Severity of Helicobacter pylori Infection with Peripheral Blood Neutrophil to Lymphocyte Ratio and Mean Platelet Volume. Euroasian J Hepatogastroenterol. 2017;7(1):11-6.
